Publication | Closed Access

Design, synthesis, biological evaluation and in silico studies of EGFR inhibitors based on 4-oxo-chromane scaffold targeting resistance in non-small cell lung cancer (NSCLC)

MedicinePharmacologyEgfr InhibitorsBronchial Neoplasm4-Oxo-chromane ScaffoldSilico StudiesCancer TreatmentLung CancerAnti-cancer AgentOncologyRadiation OncologyTumor MicroenvironmentDrug Discovery